| Primary |
| Metastatic Renal Cell Carcinoma |
34.8% |
| Renal Cell Carcinoma |
13.4% |
| Breast Cancer Metastatic |
7.3% |
| Breast Cancer |
5.9% |
| Prophylaxis |
5.1% |
| Hypertension |
4.8% |
| Pancreatic Neuroendocrine Tumour |
4.0% |
| Tuberous Sclerosis |
4.0% |
| Renal Cancer |
3.8% |
| Neuroendocrine Tumour |
2.9% |
| Pain |
2.1% |
| Carcinoid Tumour |
1.7% |
| Diabetes Mellitus |
1.7% |
| Metastatic Malignant Melanoma |
1.5% |
| Renal Cancer Metastatic |
1.5% |
| Neoplasm |
1.3% |
| Acute Myeloid Leukaemia |
1.2% |
| Glioblastoma Multiforme |
1.2% |
| Neoplasm Malignant |
1.1% |
| Nausea |
1.0% |
|
| Death |
27.0% |
| Neoplasm Malignant |
8.7% |
| Vomiting |
8.5% |
| Stomatitis |
7.9% |
| Pyrexia |
5.0% |
| Neoplasm Progression |
3.9% |
| Malignant Neoplasm Progression |
3.9% |
| Pneumonitis |
3.9% |
| Pneumonia |
3.5% |
| Thrombocytopenia |
3.3% |
| Rash |
3.1% |
| Weight Decreased |
3.0% |
| Lung Disorder |
2.4% |
| Pleural Effusion |
2.4% |
| Renal Failure |
2.4% |
| Diarrhoea |
2.3% |
| Drug Ineffective |
2.3% |
| Dyspnoea |
2.1% |
| Urinary Tract Infection |
2.1% |
| Malaise |
2.1% |
|
| Secondary |
| Metastatic Renal Cell Carcinoma |
42.0% |
| Prophylaxis |
9.1% |
| Breast Cancer Metastatic |
8.5% |
| Pancreatic Neuroendocrine Tumour |
5.4% |
| Renal Cell Carcinoma |
4.9% |
| Breast Cancer |
3.8% |
| Hypertension |
3.6% |
| Neuroendocrine Tumour |
3.3% |
| Tuberous Sclerosis |
3.2% |
| Carcinoid Tumour |
3.0% |
| Pain |
2.3% |
| Diabetes Mellitus |
1.7% |
| Astrocytoma, Low Grade |
1.3% |
| Renal Cancer |
1.2% |
| Constipation |
1.2% |
| Renal Cancer Metastatic |
1.2% |
| Product Used For Unknown Indication |
1.1% |
| Convulsion |
1.1% |
| Metastases To Bone |
1.1% |
| Hepatic Neoplasm Malignant |
1.0% |
|
| Stomatitis |
11.7% |
| Pyrexia |
10.7% |
| Vomiting |
9.7% |
| Neoplasm Malignant |
7.9% |
| Weight Decreased |
6.0% |
| Haemoglobin Decreased |
5.0% |
| Platelet Count Decreased |
4.5% |
| C-reactive Protein Increased |
4.3% |
| Death |
4.2% |
| Thrombocytopenia |
4.0% |
| Diarrhoea |
3.9% |
| Pneumonitis |
3.9% |
| Urinary Tract Infection |
3.9% |
| Malaise |
3.3% |
| Neoplasm Progression |
3.2% |
| Malignant Neoplasm Progression |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
| Rash |
2.8% |
| Lymphocyte Count Decreased |
2.7% |
| Hyperglycaemia |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.6% |
| Metastases To Bone |
12.6% |
| Renal Cancer |
10.5% |
| Breast Cancer |
9.6% |
| Breast Cancer Metastatic |
7.9% |
| Renal Cell Carcinoma |
6.3% |
| Neuroendocrine Tumour |
2.9% |
| Pain |
2.9% |
| Carcinoid Tumour |
2.1% |
| Neoplasm Malignant |
2.1% |
| Cough |
1.7% |
| Diabetes Mellitus |
1.7% |
| Disease Progression |
1.7% |
| Metastatic Renal Cell Carcinoma |
1.7% |
| Nausea |
1.7% |
| Neuroendocrine Carcinoma Metastatic |
1.7% |
| Prophylaxis |
1.7% |
| Back Pain |
1.3% |
| Bone Cancer |
1.3% |
| Carcinoid Syndrome |
1.3% |
|
| Death |
10.0% |
| Febrile Neutropenia |
10.0% |
| Weight Decreased |
8.3% |
| Osteonecrosis Of Jaw |
6.7% |
| Pain In Extremity |
6.7% |
| Diarrhoea |
5.0% |
| Disease Progression |
5.0% |
| Mouth Ulceration |
5.0% |
| Swelling Face |
5.0% |
| Syncope |
5.0% |
| Dementia |
3.3% |
| Drug Ineffective |
3.3% |
| General Physical Health Deterioration |
3.3% |
| Grand Mal Convulsion |
3.3% |
| Jaundice Cholestatic |
3.3% |
| Malaise |
3.3% |
| Mesenteric Occlusion |
3.3% |
| Nasal Congestion |
3.3% |
| Oral Pain |
3.3% |
| Pain |
3.3% |
|
| Interacting |
| Epilepsy |
30.4% |
| Acute Myeloid Leukaemia |
21.5% |
| Astrocytoma, Low Grade |
15.2% |
| Renal Cell Carcinoma |
10.1% |
| Glioblastoma Multiforme |
3.8% |
| Pain |
3.8% |
| Breast Cancer |
2.5% |
| Breast Cancer Metastatic |
2.5% |
| Hypertension |
2.5% |
| Renal Cancer |
2.5% |
| Insomnia |
1.3% |
| Metastases To Bone |
1.3% |
| Product Used For Unknown Indication |
1.3% |
| Sedative Therapy |
1.3% |
|
| Drug Interaction |
37.5% |
| Complex Partial Seizures |
12.5% |
| Cough |
6.3% |
| Hepatotoxicity |
6.3% |
| Pneumonitis |
6.3% |
| Vaginal Discharge |
6.3% |
| Blood Oestrogen Increased |
3.1% |
| Gamma-glutamyltransferase Increased |
3.1% |
| Osteonecrosis Of Jaw |
3.1% |
| Renal Failure |
3.1% |
| Spinal Pain |
3.1% |
| Status Epilepticus |
3.1% |
| Vomiting |
3.1% |
| Weight Decreased |
3.1% |
|
